Oncology
Thematic poster
Diagnosis and therapy of lung cancer
LATE-BREAKING ABSTRACT: Novel rapid screening assay for HER2 duplicated insertion mutation by Eprobe-PCR method
Y. Takase(Gunma Pref., Japan)
COI
1
Feasibility of lung cancer screening in a population of patients with emphysema and/or COPD meeting NLST criteria
S. Vicente Antunes(Madrid, Spain)
COI
2
Differences in epidemiological and clinical features in non-small cell lung cancer (NSCLC) in never and ever smokers
C. De Sousa Saraiva(Portimão, Portugal)
COI
3
Serum platelet, MPV, PCT and PDW values, neutrophil to lymphocyte and platelet to lymphocyte ratios in lung cancer diagnosis
F. Şahin(Istanbul, Turkey)
COI
4
Change in cardiorespiratory fitness after lung resection is not related to the amount of lung tissue removed
E. Edvardsen(Oslo, Norway)
COI
5
Predicted versus observed pulmonary function and peak oxygen uptake after lung cancer surgery
E. Edvardsen(Oslo, Norway)
COI
6
Surgical treatmment non-small cell lung cancer in the elderly patients
A. Reshetov(St. Petersburg, Russian Federation)
COI
7
Surgical treatment outcomes on early-stages of non-small-cell lung cancer
I. Mejri Ep Ajili(Hammamlif Ben Arous, Tunisia)
COI
8
Characteristics of smoking behaviour in patients post-curative resection of stage 1 lung cancer
R. Smyth(Dublin 9, Ireland)
COI
9
Narrow band imaging (NBI) bronchoscopy in detection and characterization of X-ray negative bronchial lesions
A. Strunina(Yaroslavl (Yaroslavl Oblast), Russian Federation)
COI
10
Autofluorescence bronchoscopy usefulness in endoscopic bronchial stump follow up
N. Toledo Pons(Palma De Mallorca, Spain)
COI
11
Relationship of T status and metastasis according to new clinical TNM staging in non small cell lung carcinoma
H. Ozkan Yilmaz(Ordu, Turkey)
COI
12
Non-small cell lung cancer: Are M1a and M1b the same stage?
M. de Pinho Dias(Vila Nova de Gaia, Portugal)
COI
13
Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC)
G. Soussi(Maisons-Alfort, France)
COI
14
The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer
S. Lee(Jinju, Republic of Korea)
COI
15
Gene therapy with DDMC-p53 with or without cisplatin and microwave ablation. A future concept for local treatment in lung cancer
P. Zarogoulidis(Thessaloniki, Greece)
COI
16
TTF 1- expression and pemetrexed based chemotherapy. A retrospective analysis
C. Steppert(Coburg, Germany)
COI
17
Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
K. Yoshimura(Tokyo, Japan)
COI
18
Prognostic factors in non-small cell lung cancer
O. Lamine(Ariana, Tunisia)
COI
19
Metabolomic profiles in lung cancer subjects and healthy controls. Influence of smoking tobacco exposure
R. Aguilar Perez Grovas(Marbella, Spain)
COI
20
. . .
